Loading organizations...
Loading organizations...
Developing antiviral therapies for respiratory viral infections.
Atriva Therapeutics has raised $42.1M across 3 funding rounds.
Atriva Therapeutics has raised $42.1M in total across 3 funding rounds.
Atriva Therapeutics has raised $42.1M in total across 3 funding rounds.
Atriva Therapeutics's investors include Ambroise Fayolle, Frank Hensel, Paul Lelieveld, High-Tech Grunderfonds, Stichting Participatie Atriva.
Atriva Therapeutics has raised $42.1M across 3 funding rounds. Most recently, it raised $28.3M Debt in October 2020.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Oct 20, 2020 | $28.3M Debt | Ambroise Fayolle | |
| Aug 19, 2020 | $10.3M Other Equity | Frank Hensel, Paul Lelieveld | |
| Sep 22, 2017 | $3.6M Seed | High-Tech Grunderfonds, Stichting Participatie Atriva |